PBDEs are industrial substances widely used as flame retardants in several commercial products including plastics, textiles, household and electronic equipment because of their efficient performance, good thermal stability and low-cost (Wen et al. 2015). Their dioxin-like properties and structural similarity to endocrine hormones, such as thyroid hormones (THs) and thyroxine (T4) in particular, have warned about neurodevelopmental and endocrine disrupting effects in humans (Butryn et al. 2020). This has led several countries, as in Canada since 2008, the UE since 2012 or the US since 2004, to ban the use of some commercial PBDEs mixtures and the Stockholm Convention on Persistent Organic Pollutants (POPs) decided to include them in the list of POP substances. In contrast to bound flame retardants, for example tetrabromobisphenol A (TBBPA), PBDEs are easily removed from products and enter the environment (Liu et al. 2020). Nowadays, and even though PBDEs are being phased out, as a result of their persistence on the environment, long-term use and recycling processes, these chemicals are still detected in a wide range of biological and environmental samples (Klinčić et al. 2020). Bioaccumulation and biomagnification of PBDEs (Liu et al. 2020) and the consequent consumption through diet, together with inhalation or accidental ingestion of dust (De la Torre et al. 2020) have led to detect potentially dangerous levels in humans (milk, blood plasma and adipose tissue) (Klinčić et al. 2020).
Also the natural metabolites as hydroxylated (OH-BDE) and methoxylated (MeO-BDE) and, recently, diOH-BDEs (Zhang et al. 2020), have been found in a wide diversity of environmental samples (Sun et al. 2020). Several studies have evidenced that metabolites maintain bioactive remains, exhibiting similar or even greater toxicity than the native PBDEs due to their hydrophobic properties (Liu et al., 2011; Usenko et al. 2012) raising the concern about these compounds.
Metabolites are biotransformation products of PBDEs, oxidated by hepatic cytochrome P450 (CYP) enzymes (Li et al. 2010) and have been found in several marine and freshwater animals as mussels, shellfish, fish, clam and whale (Liu et al. 2014; Rotander et al. 2012; Valters et al. 2005). Besides, they are also known to have a natural occurrence in the environment (Malmvärn et al. 2005; Wiseman et al. 2011). However, there are mixed reports depending on the studied organism. Therefore, the bioaccumulation, biotransformation and toxicity in different organisms of these emerging pollutants and their metabolites are still being studied because their behaviour in the environment is unknown or remains unclear.
Bioaccumulation is the process by which a compound is uptake by an organism via any route, including respiration, ingestion, or direct contact. The degree of bioaccumulation is expressed by the bioaccumulation factor (BAF), defined experimentally as the ratio between the concentration of the analyte in the organism and its surrounding medium, such as sediment or soil, and also by the biomagnification factor (BMF), in this case, the concentration of a substance in test organism divided by the concentration in the food. Also for aquatic species the bioconcentration factor (BCF) is used (El-Amrani et al. 2012), which does not take into account the uptake of a substance through the diet and can therefore only be estimated under controlled laboratory conditions (Arnot and Gobas 2006).
The official method for assessing the bioconcentration factors of chemicals is the Organisation for Economic Co-operation and Development (OECD) Test 305 (OECD 2012), which is also proposed by REACH (European Regulation for the Registration, Evaluation and Authorisation of Chemicals) as the guide to evaluate bioconcentration of a substance (REACH 2006). This test evaluates the ratio between the concentration in adult fishes and the surrounding medium after reaching the steady state, requiring many adult fish (up to 104) and long exposure time (up to 60 days), which involves a high cost of the experiments. On the other hand, European REACH and other testing legislation propose wherever possible to change animal experiments with non-animal approaches (Quantitative Structure Activity Relationship (QSAR) approximations, microorganisms, in vitro studies with cell lines, embryos etc.). Therefore, an alternative to the OECD 305 assay has recently been developed with promising results using the eleutheroembryos zebrafish (Danio rerio) (Sanz-Landaluze et al. 2015), as European legislation considers eleutheroembryos fish as in vitro systems up to the self-feeding stage (2010/63/EU 2010). Due to their high production, low cost, fast embryonic development, fast bioaccumulation kinetics, their transparency and high genomic homology with humans (over 80%), zebrafish in its first developmental stages is gaining interest in ecotoxicology model organism (Lillicrap et al. 2016). In addition, because thyroid hormone regulators are highly conserved among vertebrate species, zebrafish is a useful model to investigate compounds in relation to thyroid hormone (Vancamp, Houbrechts, and Darras 2019) to assess the risk and metabolic pathways of contaminants to animals and humans.
Due to their high use, persistence in the environment, bioavailability (log Kow 6.81) (Pereira et al. 2016) and toxicity (LC50 4.2 mg·L− 1) (Usenko et al. 2011), 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47), is one of most investigated PDBEs. BDE-47 in zebrafish has been investigated in some studies (Liu et al. 2015; Wen et al. 2015; Zheng et al. 2012) but information on the full spectrum of potential metabolites and the metabolic pathways involved is still scarce and very underdeveloped without official testing or regulation. Therefore, in addition to the bioconcentration study of BDE-47, a metabolic study was also carried out using the most abundant metabolites found in different species in the various studies realized (Lacorte, Ikonomou and Fischer 2010; Liu et al. 2015; Wen et al. 2015; Zhai et al. 2014) which are: 6-MeO-BDE-47, 5-MeO-BDE-47, 3-MeO-BDE-47, 6-OH-BDE-47, 5-OH-BDE-47, 3-OH-BDE-47 and 2’-OH-BDE-28.
It is important to bear in mind that zebrafish eleutheroembryos samples have a very small size (0.44 mg/larva), a high lipid content (~ 15%) and that exposure concentrations are always below toxicological values (< 1% of LC50). Therefore, the determination methodologies implemented must be extremely sensitive. Conventional Soxhlet has been traditionally the most used extraction method for PBDE from solid samples in a large variety of matrices. Nowadays, there is a trend to use more environmentally friendly methods such as pressurized liquid extraction (PLE) or ultrasound-assisted extraction (UAE) (Lacorte et al. 2010). The cleaning methods used for the analysis of this type of contaminants are usually solid phase extraction (SPE) or gel permeation chromatography (GPC) (Cruz et al. 2017). In this sense, in order to minimize solvent use and sample treatment time, while maintaining an acceptable recovery, the analytical protocol we devised, is based on simultaneous miniaturized extraction with a dispersive SPE clean-up, considering the difference in polarity of the PBDEs and their metabolites (MeO-BDEs and OH-BDEs). GC-MS is the most common routinely technique employed for the determination of PBDEs and MeO-PBDEs (Shelepchikov et al. 2019). However, for determination of OH-BDEs and MeO-BDEs liquid chromatography is often used (Song et al. 2020) due to their relatively high polarity (Zhai et al. 2014). In addition, the official method of the Environmental Protection Agency (EPA) for the detection of PBDEs are based on electron captured detector (ECD), because is the most sensitive detector. For this reason, a simultaneously GC-MS-µECD detection by previous derivatization of OH-BDEs was carried out to determine the BDE-47 and its metabolites under the same instrumental conditions.